Related Experiment Video
Updated: Aug 19, 2026
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Antibiotics for pneumonia therapy
1Division of Infectious Diseases, McMaster University, Hamilton, Ontario, Canada.
Abstract:
When treating any infectious disease, a physician selects an antimicrobial based on the following considerations: the in vitro activity of the drug, its pharmacokinetic properties, the efficacy data based on properly designed and conducted clinical trials, and finally the adverse effects. In this article, all of these factors, with the exception of adverse effects, were discussed. It was neither my intent nor my purpose to deal with side effects or adverse drug reactions because these are well covered in standard texts or physician references such as the Physicians' Desk Reference and the American Hospital Formulary Service (United States) and the Compendium of Pharmaceuticals and Specialties (Canada).
Insights
Physicians choose antimicrobials by considering in vitro activity, pharmacokinetics, and clinical trial efficacy. This article focuses on these factors, excluding adverse drug effects, which are detailed elsewhere.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Antimicrobial selection is crucial for treating infectious diseases effectively.
- Physicians consider multiple factors when prescribing antimicrobial agents.
- Standard references comprehensively cover antimicrobial adverse effects.
Purpose of the Study:
- To discuss key factors in antimicrobial selection for infectious diseases.
- To focus on in vitro activity, pharmacokinetics, and clinical efficacy.
- To exclude adverse drug reactions from the scope of this review.
Main Methods:
- Review of antimicrobial selection criteria.
- Analysis of in vitro drug activity data.
- Evaluation of pharmacokinetic properties of antimicrobials.
- Examination of clinical trial efficacy data.
Main Results:
- In vitro activity, pharmacokinetics, and clinical efficacy are primary considerations for antimicrobial selection.
- Detailed discussion of these factors is essential for optimal treatment outcomes.
- Adverse effects, while important, are deliberately omitted to maintain focus.
Conclusions:
- Antimicrobial selection requires a multifaceted approach, prioritizing drug activity, pharmacokinetics, and proven efficacy.
- Understanding these core elements is vital for physicians managing infectious diseases.
- This article provides a focused review on critical antimicrobial selection parameters, excluding adverse effects.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
03:22Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:14Atypical Pneumonia
01:29Pneumonia I: Introduction